Letrozole introduced in 1997 as Femara by Novartis and has been authorized to be used for the treatment of breast cancer in women in menopause by reducing the levels of estrogen in the body. Letrozole is aromatase inhibitor and is a popular bodybuilding world, where it is used to reduce the estrogen-related effects of steroid use, such as water retention and gynecomastia.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about FEMAMED 2.5 by Deus Medical, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.